Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06072833 · ClinicalTrials.gov registry record · NA
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
A NA study of Cancer in Adolescence, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06072833 is a NA study of Cancer in Adolescence that has completed, run by Columbia University. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06072833, a NA study of Cancer in Adolescence, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aims of this study are to address two important gaps in care for AYA cancer patients: 1) a financial toxicity measurement tool to assess AYA-specific needs, and 2) an intervention for mitigating financial toxicity in this population. Aim 1 involves adapting the COSTA measure and assessing the psychometric properties of the measure for a racial/ethnically diverse group of AYAs. Aim 2 and 3 involve the development and pilot testing of our novel financial education/ navigation (FE/FN) intervention.
Conditions Studied
Interventions
- BEHAVIORAL Patient Financial Education / Navigation
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06072833
The ClinicalTrials.gov registry entry for NCT06072833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer in Adolescence appearing as the primary indexed condition, and to 1 intervention - of which Patient Financial Education / Navigation is the first listed.
NCT06072833 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06072833 about?
NCT06072833 is a clinical study titled "Characterizing and Addressing Financial Toxicity in AYAs With Cancer". The overall aims of this study are to address two important gaps in care for AYA cancer patients: 1) a financial toxicity measurement tool to assess AYA-specific needs, and 2) an intervention for mitigating financial toxicity in this population. Aim 1 involves adapting the COSTA measure and assessin...
What is the current status of trial NCT06072833?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-11-15. Estimated completion is 2025-02-28.
What conditions does trial NCT06072833 study?
This clinical trial studies the following conditions: Cancer in Adolescence.
What interventions are being tested in trial NCT06072833?
The interventions under investigation include: Patient Financial Education / Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06072833?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06072833 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer in Adolescence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.